WST
West Pharmaceutical Services Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.04% · Russell 1000 0.04% · US Stock Market 0.04% · Russell 3000 0.03% · MSCI World 0.03% · MSCI ACWI 0.02%$362.31-1.17%
as of market close, Sep 18, 2026
☾ AH — —
WST financial statements
The full income statement, balance sheet, and cash-flow statement for West Pharmaceutical Services Inc. (WST), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 72.5M2024-09 72.4M2024-12 72.3M2025-03 71.8M2025-06 71.9M2025-09 71.9M2025-12 72.0M2026-03 70.6M2026-06 70.4M-3.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 3.07B+6.3% | 2.89B-1.9% | 2.95B+2.2% | 2.89B+2.0% | 2.83B+31.9% | |
| 1.10B+10.6% | 999M-11.6% | 1.13B-0.6% | 1.14B-3.4% | 1.18B+53.1% | ||
| Cost of revenue | 1.97B+4.0% | 1.89B+4.1% | 1.82B+4.0% | 1.75B+5.7% | 1.66B+20.1% | |
| Research & development | 74.3M+7.5% | 69.1M+1.0% | 68.4M+16.9% | 58.5M+10.8% | 52.8M+12.6% | |
| Selling, general & administrative | 394M+16.3% | 339M-4.2% | 353M+11.5% | 317M-12.7% | 363M+20.1% | |
| Amortization of intangibles | 2.80M-22.2% | 3.60M+0.0% | 3.60M-2.7% | 3.70M-31.5% | 5.40M+22.7% | |
| Operating income | 585M+2.6% | 570M-15.7% | 676M-7.9% | 734M-2.4% | 752M+84.9% | |
| Interest expense | 500K-83.3% | 3.00M-66.7% | 9.00M+13.9% | 7.90M-3.7% | 8.20M+0.0% | |
| Other non-operating income | -1.00M+0.0% | -1.00M-104.5% | 22.0M+142.9% | -51.3M-1450.0% | 3.80M+216.7% | |
| Equity-method income | 14.4M-2.0% | 14.7M-16.9% | 17.7M-14.5% | 20.7M+3.0% | 20.1M+15.5% | |
| Gain (loss) on equity securities | — | — | — | — | -4.60M | |
| Pre-tax income | 601M+2.6% | 586M-16.1% | 698M+2.7% | 680M-9.2% | 749M+86.6% | |
| Income tax | 122M+13.1% | 108M-12.1% | 122M+6.6% | 115M+7.0% | 107M+47.9% | |
| Net income | 494M+0.2% | 493M-17.0% | 593M+1.3% | 586M-11.5% | 662M+91.2% | |
| $6.79+1.5% | $6.69-15.1% | $7.88+1.9% | $7.73-10.8% | $8.67+89.7% | ||
| EPS (basic) | $6.83+1.2% | $6.75-15.4% | $7.98+1.4% | $7.87-11.5% | $8.89+90.0% | |
| Weighted-avg shares (basic) | 72.3M-1.0% | 73.0M-1.7% | 74.3M-0.1% | 74.4M+0.0% | 74.4M+0.7% | |
| Weighted-avg shares (diluted) | 72.7M-1.4% | 73.7M-2.1% | 75.3M-0.7% | 75.8M-0.7% | 76.3M+0.7% | |
| Dividends per share | $0.86+4.9% | $0.82+5.1% | $0.78+5.4% | $0.74+5.7% | $0.70+6.1% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.98B+28.6% | 1.54B-20.6% | 1.94B+0.9% | 1.92B+10.2% | 1.74B+26.8% | ||
| Cash & equivalents | 791M+63.3% | 485M-43.2% | 854M-4.5% | 894M+17.3% | 763M+23.9% | |
| Accounts receivable | 574M+4.0% | 553M+7.9% | 512M+0.9% | 507M+3.8% | 489M+26.9% | |
| Inventory | 444M+17.7% | 377M-13.3% | 435M+4.8% | 415M+9.6% | 378M+17.8% | |
| Other current assets | 169M+36.0% | 124M-8.7% | 136M+31.8% | 103M-8.0% | 112M+117.1% | |
| 4.27B+17.2% | 3.64B-4.9% | 3.83B+5.9% | 3.62B+9.1% | 3.31B+18.6% | ||
| Property, plant & equipment | 1.73B+9.2% | 1.58B+11.9% | 1.41B+22.0% | 1.16B+9.5% | 1.06B+12.1% | |
| Operating lease right-of-use | 117M+12.0% | 105M+5.3% | 99.2M-5.0% | 104M+50.6% | 69.3M+1.5% | |
| Goodwill | 110M+3.7% | 106M-2.3% | 109M+1.1% | 107M-2.4% | 110M-1.1% | |
| Intangible assets | 7.70M-28.7% | 10.8M-28.5% | 15.1M-17.9% | 18.4M-20.0% | 23.0M-24.6% | |
| Deferred tax assets | 38.4M+47.7% | 26.0M+1.2% | 25.7M-60.8% | 65.6M+35.3% | 48.5M+203.1% | |
| Other non-current assets | 80.1M+7.8% | 74.3M+248.8% | 21.3M-44.5% | 38.4M-2.0% | 39.2M+67.5% | |
| 655M+19.0% | 550M-18.1% | 672M+29.4% | 519M-12.6% | 594M+18.0% | ||
| Accounts payable | 254M+6.0% | 239M-1.3% | 242M+12.5% | 215M-7.2% | 232M+9.0% | |
| Accrued liabilities | 39.2M | — | — | — | — | |
| Deferred revenue | 51.9M+4.6% | 49.6M+18.9% | 41.7M-27.2% | 57.3M+17.7% | 48.7M-4.5% | |
| Short-term & current debt | 0.00 | 0.00-100.0% | 134M+5990.9% | 2.20M-95.0% | 44.2M+1821.7% | |
| Current lease liability | 22.7M+26.8% | 17.9M+1.1% | 17.7M+10.6% | 16.0M+72.0% | 9.30M-7.9% | |
| Other current liabilities | 175M-6.9% | 188M+21.3% | 155M-15.6% | 184M+12.5% | 163M+13.8% | |
| Finance lease liability (current) | 1.50M+66.7% | 900K | — | — | — | |
| 1.09B+13.8% | 961M+1.3% | 949M+1.8% | 932M-4.8% | 978M+4.2% | ||
| Long-term debt | 203M+0.1% | 203M+178.3% | 72.8M-64.8% | 207M-1.0% | 209M-17.4% | |
| Non-current lease liability | 95.6M+16.9% | 81.8M-3.2% | 84.5M-9.1% | 93.0M+47.6% | 63.0M+4.3% | |
| Operating lease liability (total) | 118M+18.7% | 99.7M-2.4% | 102M-6.2% | 109M+50.8% | 72.3M+2.6% | |
| Finance lease liability (total) | 5.10M+70.0% | 3.00M | — | 0.00 | 0.00 | |
| Finance lease liability | 3.60M+71.4% | 2.10M | — | — | — | |
| Deferred tax liabilities | 23.0M+12.2% | 20.5M+61.4% | 12.7M-11.2% | 14.3M+191.8% | 4.90M-52.9% | |
| Other non-current liabilities | 75.2M+20.9% | 62.2M+6.3% | 58.5M+13.4% | 51.6M+35.1% | 38.2M+20.1% | |
| 3.18B+18.4% | 2.68B-6.9% | 2.88B+7.3% | 2.68B+15.0% | 2.34B+25.9% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 18.8M+0.0% | 18.8M+0.0% | 18.8M+0.0% | 18.8M+0.0% | 18.8M+0.0% | |
| Additional paid-in capital | 0.00-100.0% | 22.1M-81.6% | 120M-48.2% | 232M-6.7% | 249M-6.8% | |
| Retained earnings | 4.37B+10.6% | 3.96B+12.3% | 3.52B+17.9% | 2.99B+21.6% | 2.46B+33.0% | |
| Treasury stock | 1.11B+5.2% | 1.06B+65.8% | 638M+71.9% | 371M+61.6% | 230M+36.9% | |
| Accumulated other comprehensive income | -106M+59.1% | -258M-79.5% | -144M+21.4% | -183M-14.7% | -160M-44.3% | |
| Total liabilities & equity | 4.27B+17.2% | 3.64B-4.9% | 3.83B+5.9% | 3.62B+9.1% | 3.31B+18.6% | |
| Common shares issued | 75.3M+0.0% | 75.3M+0.0% | 75.3M+0.0% | 75.3M+0.0% | 75.3M+0.0% | |
| Common shares outstanding | 72.0M-0.4% | 72.3M-1.6% | 73.5M-0.8% | 74.1M-0.1% | 74.2M+0.3% | |
| Shares outstanding (cover) | 72.0M-0.4% | 72.3M-1.4% | 73.3M-1.1% | 74.1M-0.2% | 74.3M+0.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 755M+15.5% | 653M-15.9% | 777M+7.3% | 724M+24.0% | 584M+23.6% | ||
| Depreciation & amortization | 171M+10.3% | 155M+13.2% | 137M+13.8% | 121M-1.4% | 122M+12.1% | |
| Intangible amortization | 2.80M-22.2% | 3.60M+0.0% | 3.60M-2.7% | 3.70M-31.5% | 5.40M+22.7% | |
| Share-based compensation | 23.8M+27.3% | 18.7M-19.7% | 23.3M-1.7% | 23.7M-36.8% | 37.5M+10.3% | |
| Deferred income taxes | -13.7M-291.4% | -3.50M-109.3% | 37.5M+221.8% | -30.8M+28.2% | -42.9M-639.7% | |
| Change in receivables | -6.90M-111.7% | 58.8M+1570.0% | -4.00M-111.2% | 35.6M-71.2% | 124M+165.0% | |
| Change in inventory | 62.8M+249.5% | -42.0M-411.1% | 13.5M-72.9% | 49.8M-42.4% | 86.5M+17.4% | |
| Change in payables | 17.9M+517.2% | 2.90M-34.1% | 4.40M+257.1% | -2.80M-116.7% | 16.8M-54.1% | |
| -286M+24.5% | -379M-2.7% | -369M-27.9% | -288M-13.9% | -253M-41.0% | ||
| Capital expenditure | 286M-24.2% | 377M+4.1% | 362M+27.2% | 285M+12.3% | 253M+45.3% | |
| Free cash flow | 469M+69.6% | 276M-33.3% | 415M-5.7% | 439M+32.9% | 331M+10.9% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | 0.00-100.0% | 1.70M-74.6% | 6.70M+86.1% | 3.60M+244.0% | -2.50M-149.0% | |
| -185M+70.3% | -623M-35.5% | -460M-56.5% | -294M-74.7% | -168M-22.6% | ||
| Long-term debt issued | 0.00-100.0% | 165M | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00-100.0% | 169M+7247.8% | 2.30M-94.8% | 44.3M | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 134M-76.1% | 561M+28.0% | 438M+116.1% | 203M+47.9% | 137M+18.7% | |
| Dividends paid | 61.2M+3.6% | 59.1M+3.7% | 57.0M+5.4% | 54.1M+5.9% | 51.1M+6.2% | |
| Other financing activities | — | — | -100K | 0.00 | 0.00 | |
| FX effect on cash | 22.9M+207.0% | -21.4M-287.7% | 11.4M+208.6% | -10.5M+33.1% | -15.7M-176.6% | |
| Net change in cash | 307M+183.0% | -369M-814.1% | -40.4M-130.7% | 132M-10.5% | 147M-16.6% | |
| Interest paid | 300K-40.0% | 500K-91.7% | 6.00M-9.1% | 6.60M-17.5% | 8.00M-1.2% | |
| Income taxes paid | 125M+75.4% | 71.4M-21.4% | 90.8M-17.2% | 110M-36.1% | 172M+255.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 19.8B-16.3% | 23.7B-9.1% | 26.1B+49.5% | 17.4B-50.0% | 34.8B+65.9% | |
| P/E | 40.1×-16.5% | 48.1×+3.2% | 46.6×+68.6% | 27.6×-47.5% | 52.6×-13.2% | |
| P/S | 6.4×-21.3% | 8.2×-8.0% | 8.9×+48.6% | 6.0×-51.3% | 12.3×+25.8% | |
| P/B | 6.2×-29.3% | 8.8×-2.8% | 9.1×+28.8% | 7.1×-52.7% | 14.9×+31.8% | |
| P/FCF | 42.3×-50.7% | 85.7×+38.1% | 62.0×+38.1% | 44.9×-57.4% | 105.4×+49.6% | |
| Earnings yield | 2.5%+19.8% | 2.1%-3.1% | 2.1%-40.7% | 3.6%+90.5% | 1.9%+15.2% | |
| FCF yield | 2.4%+102.8% | 1.2%-27.6% | 1.6%-27.6% | 2.2%+134.5% | 0.95%-33.2% | |
| Dividend yield | 0.31%+24.9% | 0.25%+13.0% | 0.22%-29.5% | 0.31%+110.7% | 0.15%-35.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: WST’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all WST filings on SEC EDGAR → Not investment advice.